All In MedTech

FDA Clearance Tracker · P190002-S038

Saluda Medical Evoke SCS System; Closed Loop Stimulator (CLS) (REF: 3042)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 29, 2026

Approved

Time to decision

465 days

Received Mar 21, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P190002-S038
Device name
Saluda Medical Evoke SCS System; Closed Loop Stimulator (CLS) (REF: 3042)
Applicant location
Atarmon
Received
Mar 21, 2025
Decided
Jun 29, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P190002

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

updated firmware configuration (Therapy Firmware Th 6.4.1.0; Telemetry Firmware Te 4.3.5.0) for the Evoke® implanted closed loop stimulator (CLS) (REF: 3042)

Source documents

Other decisions for Saluda Medical Pty, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.